Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells

• Mohammad Hojjat-Farsangi ,

  * E-mail: mohammad.hojat-farsangi@ki.se

  Affiliations Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden, Department of Immunology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran

  ⨯
• Fatemeh Ghaemimanesh,

  Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

  ⨯
• Amir Hossein Daneshmanesh,

  Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden

  ⨯
• Ali-Ahmad Bayat,

  Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

  ⨯
• Jafar Mahmoudian,

  Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

  ⨯
• Mahmood Jeddi-Tehrani,

  Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

  ⨯
• Hodjatallah Rabbani,

  Affiliation Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

  ⨯
• Hakan Mellstedt

  Affiliation Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden

  ⨯